Loading stock data...

Adeshwar Meditex Limited

BSE: ADESHWAR

BSE
16.00 -0.55 (-3.32%)

Prev Close

16.55

Open Price

16

Volume

6,000

Today Low / High

16 / 16

52 WK Low / High

13.95 / 26.5

Range

15 - 17

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 16, reflecting a change of -0.55 (-3.32326%). The expected target range on the BSE is 15 - 17. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

01 Jan 16.00 0.00%
31 Dec 16.00 0.00%
30 Dec 16.65 0.00%
29 Dec 16.65 0.00%
26 Dec 16.65 0.00%
24 Dec 16.65 0.00%
23 Dec 16.65 0.00%
22 Dec 16.65 0.00%
19 Dec 16.65 0.00%
18 Dec 16.65 0.00%
17 Dec 16.60 -0.30%
16 Dec 16.65 0.00%
15 Dec 14.50 14.83%
12 Dec 14.35 18.40%
11 Dec 16.98 0.00%
10 Dec 13.95 21.72%
09 Dec 16.50 0.00%
08 Dec 16.50 0.00%

Adeshwar Meditex Limited Graph

Adeshwar Meditex Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Adeshwar Meditex Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 16.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 16.00 16.16 14.54 - 17.78
16.32 13.06 - 19.58
16.48 11.54 - 21.42
Bearish Scenario 16.00 15.84 14.26 - 17.42
15.68 12.54 - 18.82
15.52 10.86 - 20.18

Overview of Adeshwar Meditex Limited

ISIN

INE0H8J01015

Industry

Medical - Specialties

Vol.Avg

5,898

Market Cap

230,902,816

Last Dividend

0

Official Website

Visit Website

IPO Date

2021-06-28

DCF Diff

-8.23

DCF

24

Financial Ratios Every Investor Needs

Stock Rating Details for ADESHWAR

Metric Value Recommendation
Overall Rating C Sell
DCF Score 4 Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 2 Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 83.71 Cr 74.42 Cr 9.30 Cr 0.1110 0.00 Cr 0.00 Cr 3.87 Cr 2.07 Cr 1.43 4.63 Cr 0.0247
2024-03-31 79.75 Cr 71.61 Cr 8.14 Cr 0.1020 0.00 Cr 1.24 Cr 4.47 Cr 2.01 Cr 1.39 5.33 Cr 0.0252
2023-03-31 82.31 Cr 71.42 Cr 10.89 Cr 0.1323 0.00 Cr 1.72 Cr 10.17 Cr 2.07 Cr 1.44 5.45 Cr 0.0252
2022-03-31 64.62 Cr 56.80 Cr 7.82 Cr 0.1210 0.00 Cr 1.01 Cr 7.53 Cr 0.79 Cr 0.55 3.58 Cr 0.0123
2021-03-31 65.73 Cr 56.51 Cr 9.22 Cr 0.1403 0.00 Cr 1.28 Cr 4.16 Cr 1.68 Cr 1.16 4.87 Cr 0.0255

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.81 Cr 72.20 Cr 35.24 Cr 36.9594 Cr 12.46 Cr 9.65 Cr 25.82 Cr 2.95 Cr 0.00 Cr 0.00 Cr 1.11 Cr 32.8712 Cr
2024-03-31 1.16 Cr 64.04 Cr 29.13 Cr 34.9095 Cr 13.89 Cr 12.73 Cr 26.53 Cr 3.64 Cr 0.12 Cr 0.00 Cr 0.10 Cr 27.7324 Cr
2023-03-31 1.90 Cr 67.00 Cr 34.09 Cr 32.9110 Cr 16.43 Cr 14.52 Cr 24.32 Cr 4.02 Cr 0.00 Cr 0.00 Cr 0.10 Cr 31.3573 Cr
2022-03-31 0.84 Cr 72.57 Cr 41.62 Cr 30.9538 Cr 18.99 Cr 18.15 Cr 27.13 Cr 3.83 Cr 0.00 Cr 0.00 Cr 2.51 Cr 37.0856 Cr
2021-03-31 1.07 Cr 62.31 Cr 41.72 Cr 20.5823 Cr 22.45 Cr 21.38 Cr 26.11 Cr 2.39 Cr 0.00 Cr 0.00 Cr 0.08 Cr 35.8919 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 3.8006 Cr 0.5090 Cr -2.6611 Cr 3.6449 Cr 1.6485 Cr 2.8062 Cr -0.1557 Cr 2.7934 Cr -1.4322 Cr 0.0000 Cr 0.7042 Cr
2024-03-31 3.8394 Cr -0.2230 Cr -4.3633 Cr 3.8394 Cr -0.7469 Cr 1.1577 Cr 0.0000 Cr 2.0080 Cr -2.5404 Cr 0.0000 Cr -2.2061 Cr
2023-03-31 5.7669 Cr -1.1585 Cr -4.6251 Cr 3.0392 Cr -0.0164 Cr 1.9046 Cr -1.2015 Cr 2.9044 Cr -2.7223 Cr 0.0000 Cr 0.9788 Cr
2022-03-31 -2.4351 Cr -1.1557 Cr 4.4447 Cr -3.6069 Cr 0.8539 Cr 1.9210 Cr -1.1718 Cr 0.7929 Cr -3.1524 Cr 0.0000 Cr 0.8067 Cr
2021-03-31 3.1517 Cr -0.7062 Cr -3.1057 Cr 2.8282 Cr -0.6603 Cr 1.0671 Cr -0.3235 Cr 2.3405 Cr -0.9222 Cr 0.0000 Cr -11.6220 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-03-31 21.41 Cr 18.90 Cr 2.51 Cr 0.1171 1.80 Cr 0.58 Cr 0.40 1.23 Cr 0.0271
2024-12-31 21.41 Cr 18.90 Cr 2.51 Cr 0.1171 1.80 Cr 0.58 Cr 0.40 1.23 Cr 0.0271
2024-09-30 20.45 Cr 18.41 Cr 2.04 Cr 0.0999 1.65 Cr 0.45 Cr 0.32 1.10 Cr 0.0221
2024-06-30 20.45 Cr 18.41 Cr 2.04 Cr 0.0999 1.65 Cr 0.45 Cr 0.32 1.10 Cr 0.0221
2024-03-31 33.59 Cr 30.27 Cr 3.31 Cr 0.0986 2.66 Cr 1.28 Cr 0.89 1.52 Cr 0.0382

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.05 Cr 0.00 Cr 0.05 Cr 34.83 Cr 21.84 Cr 56.73 Cr 2.81 Cr 62.70 Cr 25.02 Cr
2025-03-31 2.81 Cr 0.00 Cr 2.81 Cr 38.00 Cr 25.82 Cr 66.82 Cr 2.95 Cr 72.20 Cr 35.24 Cr
2024-12-31 2.81 Cr 0.00 Cr 2.81 Cr 34.98 Cr 25.82 Cr 66.82 Cr 2.95 Cr 72.20 Cr 35.24 Cr
2024-09-30 4.45 Cr 0.00 Cr 4.45 Cr 29.41 Cr 24.81 Cr 58.84 Cr 3.20 Cr 64.57 Cr 28.75 Cr
2024-06-30 4.45 Cr 0.00 Cr 4.45 Cr 25.85 Cr 24.81 Cr 58.84 Cr 3.20 Cr 64.57 Cr 28.75 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 0.58 Cr -0.75 Cr 0.01 Cr -0.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.75 Cr
2024-12-31 0.58 Cr -0.75 Cr 0.01 Cr -0.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.75 Cr
2024-09-30 0.45 Cr 2.65 Cr 0.24 Cr -1.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.07 Cr 2.58 Cr
2024-06-30 0.45 Cr 2.65 Cr 0.24 Cr -1.25 Cr 0.00 Cr 0.00 Cr 0.00 Cr -0.07 Cr 2.58 Cr
2024-03-31 1.28 Cr -4.54 Cr 0.20 Cr 0.36 Cr -1.32 Cr 1.16 Cr 2.48 Cr 0.00 Cr -4.54 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Specialties

No stocks found in this industry.

Key Executives

Whole Time Director
Abhinandan Nagaraja Rao

Gender: male

Year Born: 1990

Whole-Time Director & Chairperson
Krishnojirao Nagaraja Rao

Gender: male

Year Born: 1949

Sales Head
Mahendra Deorukhkar

Gender: male

Year Born:

Chief Financial Officer
Prashant Rane

Gender: male

Year Born: 1984

Accounts Head - Mumbai
Sandeep Shah

Gender: male

Year Born: 1967

Executive Director
Shailesh Vinayak Rajpure

Gender: male

Year Born: 1980

Manager of Q.A
Sudhakar Mishra

Gender: male

Year Born: 1974

Company Secretary & Compliance Officer
Vishal Jain

Gender: male

Year Born:

MD & Director
Ashalata Baburao Raut

Gender: female

Year Born: 1969

Chief Research & Development Officer
Ayesha Singh

Gender: female

Year Born:

FAQs about Adeshwar Meditex Limited

Who is the CEO of the company?

The CEO is Krishnojirao Nagaraja Rao.

What is the current market price of the stock?

The current price is ₹16.00.

What is the 52-week price range?

The range is ₹13.95-26.5.

What is the market capitalization of the company?

The market capitalization is ₹23.09 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 14.41.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Adeshwar Meditex Limited (ISIN: INE0H8J01015) is a leading Medical - Specialties in India. With a market capitalization of ₹23.09 crores and an average daily volume of 5,898 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.